HealthcareServices

Cell Therapy Processing Market Size Forecast: Revenue and CAGR by 2029

November 20, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Cell Therapy Processing Industry In 2025?

The cell therapy processing market size has shown rapid expansion in recent years. It is projected to grow from $4.54 billion in 2024 to $5.18 billion in 2025, at a compound annual growth rate (CAGR) of 14.3%. The market’s growth in the preceding period can be linked to the increased adoption of cell-based therapies, rising investment in biomanufacturing infrastructure, a surge in demand for personalized medicine, the growing clinical success of cell therapies, and the escalating need for good manufacturing practices (GMP)-compliant processing systems.

The cell therapy processing market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $8.73 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 13.9%. This expansion during the projection period stems from a heightened emphasis on automated cell processing technologies, the growing incorporation of artificial intelligence (AI) into cell manufacturing processes, an escalating need for scalable allogeneic cell therapies, increased regulatory assistance for advanced therapy production, and a rise in collaborations between biotechnology companies and contract development and manufacturing organization (CDMOs). Key developments anticipated within this timeframe encompass improvements in closed-system bioreactor technologies, the creation of real-time monitoring instruments for cell cultures, breakthroughs in cryopreservation and cell storage techniques, advancements in cell separation and purification methods, and the establishment of modular and scalable good manufacturing practices (GMP) manufacturing platforms.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27244&type=smp

What Are The Top Growth Drivers Impacting The Cell Therapy Processing Market Outlook?

The increasing volume of cell therapy research endeavors is projected to drive the expansion of the cell therapy processing market. Cell therapy involves creating therapeutic products derived from living cells to treat or manage a range of conditions, including cancers, autoimmune disorders, and genetic diseases. The rising demand for cell-based therapy stems from the critical need for scalable and consistent manufacturing platforms that can support high cell densities without sacrificing product quality. Cell therapy processing provides advantages for cell therapy research by enabling standardized preparation, stringent quality control, and scalable production of high-quality cells, thus ensuring reliable and reproducible outcomes for both experimental and clinical investigations. As an illustration, in December 2024, the International Federation of Pharmaceutical Manufacturers and Associations, a Switzerland-based non-profit organization, stated that six first-in-class cell and gene treatments were launched in 2023, which signifies a 50% increase compared to the three introduced in 2022. Consequently, the expanding number of cell therapy research activities is propelling the growth of the cell therapy processing market.

What Are The Key Segments In The Cell Therapy Processing Market?

The cell therapy processing market covered in this report is segmented

1) By Offering Type: Products, Services, Software

2) By Applications: Cardiovascular Devices, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, Other Applications

3) By End-User: Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Other End-Users

Subsegments:

1) By Products: Cell Processing Systems, Cell Separation Devices, Cell Culture Equipment, Cell Preservation Systems, Consumables And Reagents

2) By Services: Contract Manufacturing Services, Process Development Services, Quality Control And Testing Services, Logistics And Supply Chain Services, Regulatory Compliance And Documentation Services

3) By Software: Cell Processing Workflow Management Software, Data Analysis And Reporting Software, Quality Management Software, Laboratory Information Management Systems (LIMS), Compliance And Audit Management Software

Which Ongoing Trends Are Expected To Shape The Cell Therapy Processing Market Outlook?

Leading companies active in the cell therapy processing market are concentrating on developing advanced solutions, such as integrated bioreactor-centrifuge systems, to optimize manufacturing workflows and enhance the consistency, scalability, and sterility of cell-based therapies. An integrated bioreactor-centrifuge system is a combined device that incorporates cell incubation and centrifugal separation within a single sealed unit, facilitating continuous, automated cell processing without requiring intermediate transfers. For instance, in March 2025, Limula SA, a Switzerland-based company manufacturing cell and gene therapy (CGT), launched LimONE, an automated, closed-system platform for cell therapy manufacturing. This innovative system merges hardware, single-use consumables, and protocol-driven software to simplify complex cell processing stages like incubation, centrifugation, and reagent handling into one compact unit, enabling consistent, scalable production of therapies such as CAR-T and gene-edited stem cells from research through to GMP-compliant manufacturing, without the need for intricate technology transfers.

Who Are The Core Companies Influencing The Cell Therapy Processing Market Landscape?

Major companies operating in the cell therapy processing market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, Gilead Sciences Inc., Danaher Corporation, Lonza Group AG, Anterogen Co. Ltd., Terumo Corporation, Sartorius AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, AGC Biologics S.p.A., MaxCyte Inc., Nkarta Inc., Cellares Corporation, Cellectis S.A., JW (Cayman) Therapeutics Company Limited, Cell Therapies Pty Ltd., and InGeneron Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report

How Is Cell Therapy Processing Market Demand Varying Across Different Regions?

North America was the largest region in the cell therapy processing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy processing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Cell Therapy Processing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27244&type=smp

Browse Through More Reports Similar to the Global Cell Therapy Processing Market 2025, By The Business Research Company

Metal Structural Insulation Panels Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/metal-structural-insulation-panels-global-market-report

Sandwich Panels Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/sandwich-panels-global-market-report

Structural Insulated Panels Market 2025

https://www.thebusinessresearchcompany.com/report/structural-insulated-panels-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795